Serum Institute of India seeks emergency use authorisation from India's drug regulator for its COVID-19 vaccine Covovax for 12 to 17 year age group— Press Trust of India (@PTI_News) February 21, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


